STEM-PD Open Label Extension (OLE)
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Scion NeuroStim
- Study ID
- NCT04799418
- Status
- Terminated
Conditions
- Parkinson Disease
- Parkinson's Disease and Parkinsonism
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Open Label Extension Study — DEVICEThis study will investigate the safety and efficacy of extended treatments for the management of symptoms related to PD.
Study Details
This study seeks to establish the safety and efficacy of extended twice daily time-varying caloric vestibular stimulation treatments for treating symptoms associated with Parkinson's disease. Only participants who completed the STEM-PD randomized controlled trial portion (NCT04797611) are eligible to participate in the open label extension portion.
Key Dates
- Start date
- Sep 15, 2022
- Status verified
- Jul 2025
- Primary completion
- Feb 24, 2025
- Completion
- Feb 24, 2025
Study Design
- Enrollment
- 148 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: passive-activeThis group received passive treatment with the study device in a randomized controlled trial (RCT) that immediately preceded this open label extension (OLE ) trial during which participants received active (i.e., time-varying caloric vestibular stimulation ) treatment.
- Experimental: active-activeThis group received active (i.e., time-varying caloric vestibular stimulation) treatment with the study device in a randomized controlled trial (RCT) that immediately preceded this open label extension (OLE) trial during which participants received active treatment. Data from participants in this arm was only used for exploratory outcomes.
Primary Outcome Measure
Change From Baseline in The International Parkinson and Movement Disorder Society - Non-Motor Rating Scale (MDS-NMS) Total Score [ Time Frame: 3 months (NCT04797611 RCT: Day 29 - Day 113; This OLE: Day 113 to Day 197) ]
Locations (15)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Movement Disorder Center of Arizona | Scottsdale | Arizona | 85258 | - |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | - |
| Parkinson's Disease and Movement Disorder of Boca Raton | Boca Raton | Florida | 33486 | - |
| Headlands Research Orlando | Orlando | Florida | 32819 | - |
| University of South Florida | Tampa | Florida | 33613 | - |
| University of Kansas Medical Center - Parkinson's Disease Center | Kansas City | Kansas | 66160 | - |
| Quest Research | Farmington Hills | Michigan | 48334 | - |
| Mercy Health Saint Mary's | Grand Rapids | Michigan | 49503 | - |
| University of New Mexico | Albuquerque | New Mexico | 87131 | - |
| Meridian Clinical Research | Raleigh | North Carolina | 27607 | - |
| Cleveland Clinic | Cleveland | Ohio | 44195 | - |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | - |
| Veracity Neuroscience | Memphis | Tennessee | 38157 | - |
| Houston Methodist Neurological Institute | Houston | Texas | 77030 | - |
| Riverside Neurology Specialists | Newport News | Virginia | 23601 | - |
Find similar trials in Scottsdale, AZ
By condition
By specialty
By research site
Movement Disorder Center of Arizona· Scottsdale, AZCedars-Sinai Medical Center· Los Angeles, CAParkinson's Disease and Movement Disorder of Boca Raton· Boca Raton, FLHeadlands Research Orlando· Orlando, FLUniversity of South Florida· Tampa, FLUniversity of Kansas Medical Center - Parkinson's Disease Center· Kansas City, KS
Related Studies
- Stereotactic Radiosurgery for Essential Tremor and Parkinsonian TremorRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Natural History Study of SynucleinopathiesRecruiting · NYU Langone Health · Boston, Massachusetts
- Effects of Stimulation Patterns of Deep Brain StimulationEnrolling By Invitation · Duke University · Gainesville, Florida
- Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailurePHASE1 · Recruiting · Vanderbilt University Medical Center · Nashville, Tennessee